I D R I Trademark

Trademark Overview


On Tuesday, July 28, 2015, a trademark application was filed for I D R I with the United States Patent and Trademark Office. The USPTO has given the I D R I trademark a serial number of 86707099. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, April 19, 2024. This trademark is owned by Infectious Disease Research Institute. The I D R I trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of tuberculosis, leishmaniasis, malaria, leprosy, pandemic flu and HIV; vaccines; adjuvants for use with vaccines; biologic formulations, diagnostic agents and pharmaceutical preparations, namely, drug delivery agents comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents for use in connection with humans and animals for the treatment of tuberculosis, leishmaniasis, malaria, leprosy, pandemic flu and HIV

Medical and scientific research in the fields of vaccines, pharmaceuticals, biologics, vaccines, adjuvants, adjuvant formulations, biologic formulations, drug delivery, diagnostics, and medical therapeutics; product research and development in the fields of pharmaceuticals, vaccines, diagnostics, adjuvants, adjuvant formulations, biologic formulations and drug delivery
i d r i

General Information


Serial Number86707099
Word MarkI D R I
Filing DateTuesday, July 28, 2015
Status710 - CANCELLED - SECTION 8
Status DateFriday, April 19, 2024
Registration Number5302024
Registration DateTuesday, October 3, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, June 14, 2016

Trademark Statements


Description of MarkThe mark consists of a helix presented horizontally with the letters "I D R I" placed within the helix.
Goods and ServicesPharmaceutical preparations for the treatment of tuberculosis, leishmaniasis, malaria, leprosy, pandemic flu and HIV; vaccines; adjuvants for use with vaccines; biologic formulations, diagnostic agents and pharmaceutical preparations, namely, drug delivery agents comprising polymer-based oral tablets for the continuous release of a wide variety of therapeutic agents for use in connection with humans and animals for the treatment of tuberculosis, leishmaniasis, malaria, leprosy, pandemic flu and HIV
Pseudo MarkINFECTIOUS DISEASE RESEARCH INSTITUTE; IDRI
Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesMedical and scientific research in the fields of vaccines, pharmaceuticals, biologics, vaccines, adjuvants, adjuvant formulations, biologic formulations, drug delivery, diagnostics, and medical therapeutics; product research and development in the fields of pharmaceuticals, vaccines, diagnostics, adjuvants, adjuvant formulations, biologic formulations and drug delivery

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 19, 2024
Primary Code005
First Use Anywhere DateFriday, February 10, 2017
First Use In Commerce DateFriday, February 10, 2017

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, April 19, 2024
Primary Code042
First Use Anywhere DateThursday, October 31, 2002
First Use In Commerce DateThursday, October 31, 2002

Trademark Owner History


Party NameInfectious Disease Research Institute
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSeattle, WA 98102

Party NameInfectious Disease Research Institute
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSeattle, WA 98102

Party NameInfectious Disease Research Institute
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSeattle, WA 98102

Trademark Events


Event DateEvent Description
Thursday, May 5, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, July 31, 2015NEW APPLICATION ENTERED
Monday, August 3, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 4, 2015NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, November 6, 2015ASSIGNED TO EXAMINER
Monday, November 9, 2015NON-FINAL ACTION WRITTEN
Monday, November 9, 2015NON-FINAL ACTION E-MAILED
Monday, November 9, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, May 5, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 6, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, August 9, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 10, 2016EXAMINERS AMENDMENT -WRITTEN
Tuesday, May 10, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, May 10, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, May 10, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, May 10, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 25, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 14, 2016PUBLISHED FOR OPPOSITION
Tuesday, June 14, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, August 11, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 6, 2017SOU TEAS EXTENSION RECEIVED
Monday, February 6, 2017SOU EXTENSION 1 FILED
Monday, February 6, 2017SOU EXTENSION 1 GRANTED
Wednesday, February 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 9, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, August 9, 2017SOU EXTENSION 2 FILED
Wednesday, August 9, 2017SOU EXTENSION 2 GRANTED
Thursday, August 10, 2017TEAS STATEMENT OF USE RECEIVED
Thursday, August 10, 2017USE AMENDMENT FILED
Friday, September 1, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 3, 2017REGISTERED-PRINCIPAL REGISTER
Monday, October 3, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Friday, April 19, 2024CANCELLED SEC. 8 (6-YR)
Thursday, August 31, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, August 28, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 31, 2017STATEMENT OF USE PROCESSING COMPLETE